Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapartum azithromycin versus postpartum amoxicillin-clavulanic acid plus metronidazole for prevention of puerperal sepsis after vaginal delivery
PACTR202605587767119Not yet recruiting
- Sponsor
- Self-sponsored
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of azithromycin, sponsored by Self-sponsored. Planned start May 2026; status: not yet recruiting.
02
Drugs
azithromycin
Beyond the preview
Go deeper on PACTR202605587767119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605587767119.